DE60123128D1 - Zuammensetzungen und verfahren zur verbesserung der nierenfunktion - Google Patents
Zuammensetzungen und verfahren zur verbesserung der nierenfunktionInfo
- Publication number
- DE60123128D1 DE60123128D1 DE60123128T DE60123128T DE60123128D1 DE 60123128 D1 DE60123128 D1 DE 60123128D1 DE 60123128 T DE60123128 T DE 60123128T DE 60123128 T DE60123128 T DE 60123128T DE 60123128 D1 DE60123128 D1 DE 60123128D1
- Authority
- DE
- Germany
- Prior art keywords
- improving
- zvegf4
- kidney function
- mammal
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000003907 kidney function Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 239000000539 dimer Substances 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 210000001985 kidney epithelial cell Anatomy 0.000 abstract 1
- 210000003251 kidney tubule epithelial cell Anatomy 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 230000004083 survival effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Orthopedic Medicine & Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- External Artificial Organs (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24447900P | 2000-10-30 | 2000-10-30 | |
| US244479P | 2000-10-30 | ||
| PCT/US2001/050155 WO2002060467A2 (en) | 2000-10-30 | 2001-10-26 | Compositions and methods for improving kidney function |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60123128D1 true DE60123128D1 (de) | 2006-10-26 |
| DE60123128T2 DE60123128T2 (de) | 2007-09-13 |
Family
ID=22922950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60123128T Expired - Fee Related DE60123128T2 (de) | 2000-10-30 | 2001-10-26 | Zuammensetzungen und verfahren zur verbesserung der nierenfunktion |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US6827938B2 (de) |
| EP (1) | EP1355655B1 (de) |
| JP (1) | JP4249482B2 (de) |
| AT (1) | ATE339218T1 (de) |
| AU (1) | AU2002248237A1 (de) |
| CA (1) | CA2427143A1 (de) |
| DE (1) | DE60123128T2 (de) |
| DK (1) | DK1355655T5 (de) |
| ES (1) | ES2272573T3 (de) |
| WO (1) | WO2002060467A2 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7135174B2 (en) * | 2002-01-07 | 2006-11-14 | Amgen Fremont, Inc. | Antibodies directed to PDGFD and uses thereof |
| CN102271692B (zh) | 2008-11-12 | 2014-05-21 | 坦吉恩股份有限公司 | 分离的肾细胞及其用途 |
| KR101913874B1 (ko) | 2010-11-10 | 2018-10-31 | 인리젠 | 장기 확대를 위한 주사가능 제제 |
| US11123372B2 (en) | 2016-07-29 | 2021-09-21 | Prokidney | Bioactive renal cells for the treatment of chronic kidney disease |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6706687B1 (en) | 1998-11-10 | 2004-03-16 | Ludwig Institute For Cancer Research | Platelet-derived growth factor D |
| AU4008500A (en) | 1999-04-06 | 2000-10-23 | Eli Lilly And Company | Platelet-derived growth factor related gene and protein |
| US6468543B1 (en) * | 1999-05-03 | 2002-10-22 | Zymogenetics, Inc. | Methods for promoting growth of bone using ZVEGF4 |
| US6630142B2 (en) * | 1999-05-03 | 2003-10-07 | Zymogenetics, Inc. | Method of treating fibroproliferative disorders |
| AU7868000A (en) | 1999-10-07 | 2001-05-10 | Curagen Corporation | Growth factor polypeptides and nucleic acids encoding same |
| WO2001089450A2 (en) | 2000-05-19 | 2001-11-29 | Eli Lilly And Company | Treating musculoskeletal disorders using lp85 and analogs thereof |
| US20020173453A1 (en) | 2000-12-15 | 2002-11-21 | Rama Akella | Method of treating renal injury |
-
2001
- 2001-10-26 DK DK01997117T patent/DK1355655T5/da active
- 2001-10-26 ES ES01997117T patent/ES2272573T3/es not_active Expired - Lifetime
- 2001-10-26 AT AT01997117T patent/ATE339218T1/de not_active IP Right Cessation
- 2001-10-26 CA CA002427143A patent/CA2427143A1/en not_active Abandoned
- 2001-10-26 US US10/039,847 patent/US6827938B2/en not_active Expired - Fee Related
- 2001-10-26 AU AU2002248237A patent/AU2002248237A1/en not_active Abandoned
- 2001-10-26 EP EP01997117A patent/EP1355655B1/de not_active Expired - Lifetime
- 2001-10-26 DE DE60123128T patent/DE60123128T2/de not_active Expired - Fee Related
- 2001-10-26 JP JP2002560658A patent/JP4249482B2/ja not_active Expired - Fee Related
- 2001-10-26 WO PCT/US2001/050155 patent/WO2002060467A2/en active IP Right Grant
-
2004
- 2004-09-10 US US10/938,041 patent/US20050049217A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002060467A3 (en) | 2003-08-21 |
| JP4249482B2 (ja) | 2009-04-02 |
| US20050049217A1 (en) | 2005-03-03 |
| ATE339218T1 (de) | 2006-10-15 |
| DE60123128T2 (de) | 2007-09-13 |
| DK1355655T3 (da) | 2007-01-15 |
| DK1355655T5 (da) | 2007-08-13 |
| AU2002248237A1 (en) | 2002-08-12 |
| WO2002060467A2 (en) | 2002-08-08 |
| EP1355655B1 (de) | 2006-09-13 |
| ES2272573T3 (es) | 2007-05-01 |
| US20020183273A1 (en) | 2002-12-05 |
| JP2004518681A (ja) | 2004-06-24 |
| CA2427143A1 (en) | 2002-08-08 |
| EP1355655A2 (de) | 2003-10-29 |
| US6827938B2 (en) | 2004-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mann et al. | Solubilization of protein BM‐40 from a basement membrane tumor with cheating agents and evidence for its identity with osteonectin and SPARC | |
| ATE333464T1 (de) | Zusammensetzungen und verfahren zur behandlung von infektionen unter verwendung von kationischen peptiden allein oder in kombination mit antibiotika | |
| CY1117358T1 (el) | ΔΙΑΛΥΤΗ ΓΛΥΚΟΠΡΩΤΕΪΝΗ ΥΑΛΟΥΡΟΝΙΔΑΣΗΣ (sHASEGP), ΔΙΑΔΙΚΑΣΙΑ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ ΤΗΣ, ΧΡΗΣΕΙΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΛΑΜΒΑΝΟΥΝ | |
| DK0661989T3 (da) | Proteinsammensætninger med vedvarende frigivelse | |
| EP0921818A4 (de) | Therapeutische und diagnostische verfahren und zusammensetzungenauf der basis von jagged/notch-proteinen und aminosäuren | |
| ES2178000T3 (es) | Composiciones y metodos para tratar infecciones usando analogos de indolicidina. | |
| ATE352617T1 (de) | Lösliche polypeptidfraktionen des lag-3-proteins; verfahren zur herstellung; therapeutische zusamensetzung; antiidiotypischer antikörper | |
| ATE348883T1 (de) | Zusammensetzungen und verfahren mit analogen von g-csf | |
| ATE294504T1 (de) | Verfahren und zusammensetzungen zur behandlung von zellproliferationsstörungen | |
| ATE257160T1 (de) | Peptidsequenzen als scharnierregionen in proteinen wie immunglobulinfragmenten und ihre verwendung in der heilkunde | |
| YU71800A (sh) | Hibridni polipeptidi sa pojačanim farmakokinetičkim osobinama | |
| PT662827E (pt) | Metodos de diagnostico e composicoes farmaceuticas a base de proteinas notch e acidos nucleicos | |
| DK1265914T3 (da) | WNT-1-relaterede polypeptider og nukleinsyrer, der koder for samme | |
| Wilkinson | The components of troponin from chicken fast skeletal muscle. A comparison of troponin T and troponin I from breast and leg muscle | |
| ATE404583T1 (de) | Funktionelle antagonisten von hedgehog-aktivität | |
| DE69132902D1 (de) | Methoden zur identifizierung heterofunktionaler fusionsproteine | |
| WO2000034474A3 (en) | Growth factor homolog zvegf3 | |
| RS49517B (sr) | PEPTID p277-ANALOZI I FARMACEUTSKI PREPARATI KOJI GA SADRZE | |
| DE60123128D1 (de) | Zuammensetzungen und verfahren zur verbesserung der nierenfunktion | |
| Piez et al. | The order of the CNBr peptides from the α1 chain of collagen | |
| ES2192199T3 (es) | Ligandos de la familia eph biologicamente activos. | |
| TR200000416T2 (tr) | Neisseria loctoferrin bağlayıcı protein. | |
| Garcia-Pardo et al. | Primary structure of human plasma fibronectin—characterization of the 6,000 dalton C-terminal fragment containing the interchain disulfide bridges | |
| MXPA01011158A (es) | Factor de crecimiento homologo zvegf4. | |
| ATE135407T1 (de) | Peptide, welche hiv-retroviren-hemmende antikörper induzieren, sowie gegen diese peptide gerichtete antikörper |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |